Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN
SUSTAIN 9: Ozempic injection as an add-on to SGLT-2i MET/SU 6 Study design: 30-week, multinational, randomized, double-blind, parallel-group, placebo-controlled trial evaluating the efficacy and safety of adding Ozempic injection 1 mg to SGLT-2i metformin/sulfonylurea vs SGLT-2i + placebo metformin/sulfonylurea
The same amount of the developer (creme oxide) was added to the hair dye (1:1 mixture)
Shortages have been common due to their popularity
Compounded semaglutide products are not reviewed or approved by the FDA for safety, effectiveness, or manufacturing consistency, and some formulations may involve different ingredients, concentrations, or semaglutide salts that differ from Novo Nordisks approved medications
Sean Wharton, and the anonymous reviewers who contributed to the refinement of this guideline